ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2673

Quantitative 18F-FDG PET/CT analysis reveals new patterns of muscle involvement and prognostic indicators in idiopathic inflammatory myopathies: beyond proximal muscle weakness

Fatma Basibuyuk1, Melih Yigithan Bahadir2, Gokce Kenar Artin2, Amac Kiray2, Recep Bekis2 and İsmail Sari2, 1Dokuz Eylul University, Izmir, Turkey, 2Dokuz Eylül University, İzmir, Izmir, Turkey

Meeting: ACR Convergence 2025

Keywords: dermatomyositis, Imaging, Myositis, prognostic factors

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Wednesday, October 29, 2025

Title: Abstracts: Muscle Biology, Myositis & Myopathies – Basic & Clinical Science I: Diagnostics & Therapeutics (2669–2674)

Session Type: Abstract Session

Session Time: 12:30PM-12:45PM

Background/Purpose: To characterize muscle involvement in idiopathic inflammatory myopathies (IIMs) using detailed anatomical segmentation and volumetric 18F-FDG PET/CT analysis, and to evaluate the prognostic value of global metabolic burden compared to SUVmax.

Methods: Patients with IIMs undergoing baseline 18F-FDG PET/CT were retrospectively analyzed. Clinical and laboratory data (CK, AST, LDH, CRP, ESR) were collected. Severe or refractory disease was defined clinically. Each muscle group was individually assessed, then categorized into five regions (head/neck, thorax, abdomen, upper and lower extremities) based on anatomical curricula. PET parameters included SUVmax (peak activity), metabolic lesion volume (MLV), and total lesion glycolysis (TLG; SUVmean × MLV). Log-transformation normalized data. Pearson correlations and nonparametric tests assessed associations. ROC analysis after logistic regression evaluated prognostic performance.

Results: Twenty-one patients [median age 62 (range 22–77); 76.2% female] were included. Diagnoses were dermatomyositis (71.4%), polymyositis (23.8%), and antisynthetase syndrome (4.8%). Median follow-up was 11.5 months. Detailed anatomical segmentation (Table 1) revealed that thoracic muscles, particularly autochthonous thoracic and thoracic wall muscles, had the highest MLV and TLG values (median TLG: 115.99 thorax vs. 127.5 lower extremities). Lower extremities also showed significant burden, whereas abdominal and head/neck muscles were less involved (Figure 1). At follow-up, 33.3% (7/21) developed severe disease and 42.9% (9/21) were refractory. SUVmax did not correlate significantly with baseline laboratory markers or outcomes. In contrast, TLG demonstrated strong correlations with AST (r=0.657, p=0.003), LDH (r=0.663, p=0.003), CRP (r=0.598, p=0.009), and ESR (r=0.549, p=0.018). ROC analysis showed that TLG (AUC 0.821) and MLV (AUC 0.803) outperformed SUVmax (AUC 0.652) in predicting severe/refractory disease (Figure 2).

Conclusion: This study provides the first detailed volumetric map of muscle inflammation in IIMs using 18F-FDG PET/CT.Thoracic and paraspinal muscles were major sites of involvement, challenging the classical focus on proximal muscles. Volumetric PET parameters, particularly TLG and MLV, more effectively captured the global inflammatory load and correlated with severe or refractory disease. These findings suggest that comprehensive volumetric PET/CT analysis may enhance diagnostic precision and risk stratification in IIMs.

Supporting image 1Table 1. Distribution of Muscle Involvement by Muscle Groups in Idiopathic Inflammatory Myopathy Patients as Assessed by 18F-FDG PET/CT (SUVmax, MLV, and TLG).

Supporting image 2Figure 1.Graphical Distribution of Muscle Group Involvement in IIM Patients Based on MLV and TLG Measurements.

Supporting image 3Figure 2. ROC Curves Comparing the Discriminative Ability of SUVmax, MLV, and TLG for Predicting Severe or Refractory Disease.


Disclosures: F. Basibuyuk: None; M. Bahadir: None; G. Kenar Artin: None; A. Kiray: None; R. Bekis: None; İ. Sari: None.

To cite this abstract in AMA style:

Basibuyuk F, Bahadir M, Kenar Artin G, Kiray A, Bekis R, Sari İ. Quantitative 18F-FDG PET/CT analysis reveals new patterns of muscle involvement and prognostic indicators in idiopathic inflammatory myopathies: beyond proximal muscle weakness [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/quantitative-18f-fdg-pet-ct-analysis-reveals-new-patterns-of-muscle-involvement-and-prognostic-indicators-in-idiopathic-inflammatory-myopathies-beyond-proximal-muscle-weakness/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/quantitative-18f-fdg-pet-ct-analysis-reveals-new-patterns-of-muscle-involvement-and-prognostic-indicators-in-idiopathic-inflammatory-myopathies-beyond-proximal-muscle-weakness/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology